Copyright
©The Author(s) 2024.
World J Gastroenterol. Jun 28, 2024; 30(24): 3086-3105
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3086
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3086
Table 1 Composition of Qingre Huashi decoction
| Authorities name | Scientific name | Plant part | Weight ratio (g) |
| Huanglian | Coptis chinensis Franch. | Rhizome | 6 |
| Zhizi | Gardenia jasminoides Ellis | Fruit | 6 |
| Pugongying | Taraxacum mongolicum Hand-Mazz. | Whole plant | 15 |
| Kuxingren | Prunus armeniaca L. var. ansu Maxim. | Seed | 10 |
| Doukouren | Amomun kravanh Pierre ex Gagnep. | Fruit | 6 |
| Yiyiren | Coix lacryma-jobi L. var. ma-yuen (Roman.) Stapf | Seed | 15 |
| Banxia | Pinellia ternata (Thunb) Breit. | Tuber | 10 |
| Cangzhu | Atractylodes lancea (Thunb.) DC. | Rhizome | 10 |
| Houpo | Magnolia Officinalis Rehd Et Wils. | Bark | 10 |
| Fuling | Poria Cocos (Schw.) Wolf. | Sclerotium | 15 |
| Cheqiancao | Plantago asiatica L. | Whole plant | 15 |
Table 2 Information of 12 Helicobacter pylori-infected individuals
| No. | Gender | Age | Gastroscopic diagnosis | Pathological diagnosis | 13C |
| 1 | M | 47 | Superficial gastritis; duodenal bulb inflammation (mild) | Mild chronic gastritis in the gastric body, activity grade II, lymphoid follicle formation, and mucosal erosion | 32.4 |
| 2 | F | 39 | Superficial gastritis | Moderate chronic gastritis in the gastric antrum, activity grade II, and mucosal erosion | 26.7 |
| 3 | F | 54 | Chronic atrophic gastritis | Mild chronic gastritis in the gastric antrum, activity grade I, mild intestinal metaplasia. Mild chronic gastritis in the gastric fundus, and severe intestinal metaplasia | 19.8 |
| 4 | M | 64 | Reflux esophagitis (LA-A); superficial gastritis; duodenal bulb ulcer (H1 stage) | Moderate chronic gastritis in the gastric antrum, activity grade II, mucosal hyperplasia, lymphoid follicle formation, and fundic gland polyp in the gastric fundus | 40.5 |
| 5 | F | 35 | Chronic non-atrophic gastritis; bile reflux | Mild chronic inflammation in the gastric body, and activity grade II. Moderate chronic gastritis in the gastric antrum, activity grade II, and lymphoid follicle formation | 42.2 |
| 6 | F | 42 | Chronic non-atrophic gastritis; Helicobacter pylori infection | Moderate chronic inflammation in the gastric antrum, and activity grade II | 27.5 |
| 7 | M | 32 | Reflux esophagitis (LA-B); hiatal hernia; chronic atrophic gastritis C2 | Moderate chronic gastritis in the gastric antrum, activity grade II | 28.9 |
| 8 | M | 34 | Chronic atrophic gastritis with intestinal metaplasia and gastric ulcer | Moderate chronic gastritis in the gastric antrum, activity grade II, mild intestinal metaplasia, mild atrophy, mucosal hyperplasia, lymphoid follicle formation. Mild chronic inflammation in the cardia, and activity grade I | 24.3 |
| 9 | F | 35 | Chronic superficial gastritis; bile reflux; duodenal bulb ulcer | Severe chronic inflammation in the gastric antrum, activity grade II, and lymphoid follicle formation | 25.4 |
| 10 | F | 40 | Hiatal hernia; chronic gastritis with intestinal metaplasia | Moderate chronic gastritis in the gastric antrum (site 1), activity grade II, mild intestinal metaplasia, and moderate glandular atrophy | 17.3 |
| 11 | F | 46 | Duodenal ulcer; chronic gastritis; bile reflux | NA | 18.3 |
| 12 | M | 42 | Superficial gastritis | Mild chronic gastritis in the gastric antrum, and focal lymphocyte aggregation | 16.4 |
Table 3 Interpretation of biofilm production
| Average optical density value | Biofilm production |
| ≤ ODc | No |
| ODc < OD ≤ 2 × ODc | Weak |
| 2 × ODc < OD ≤ 4 × ODc | Moderate |
| > 4 × ODc | Strong |
Table 4 Primer sequences for quantitative polymerase chain reaction
| Primer name | Sequence (5’→3’) | Primer name | Sequence (5’→3’) |
| 16S rRNA-F | GCTAAGAGATCAGCCTATGTCC | Spot-F | TGTGCAACCTGTCGCTAATC |
| 16S rRNA-R | TGGCAATCAGCGTCAGGTAATG | Spot-R | TTGGGCAAGATGTGGCTAAT |
| HP0605-F | AGCGCAAGAACTCAGTGTCA | LUXS-F | TGGATCACACYAAAGTCAAAG |
| HP0605-R | GCTTGGAGTTGTTGGGTGTT | LUXS-R | AAACCCCCACTTCAGACCA |
| HP1327-F | GCCAGGCTTGATGAAGAAAA | cagE-F | TTGAAAACTTCAAGGATAGGATAGAGC |
| HP1327-R | TTAGCCTGCTTGCCGTAAAT | cagE-R | GCCTAGCGTAATATCACCATTACCC |
| HP1489-F | TAGGCGCTCAAGTGGCTTAT | gluP-F | CCGCTGGTAATCCCTTTGTA |
| HP1489-R | TCAGATCGGGCAGATTTTTC | gluP-R | CTTGCATTATCGCCCATTTT |
| HP0971-F | TTACCGGCAAAGGGATACG | napA-F | TGAAGAGTTTGCGGACAT |
| HP0971-R | AAATTGGATCGCTCGTTGTATG | napA-R | AGAGTGGAAGCTCGTTTT |
Table 5 Primers sequences for polymerase chain reaction-agarose gel electrophoresis
| Primer name | Sequence (5’→3’) | Primer name | Sequence (5’→3’) |
| 16S rRNA-F | GCTAAGAGATCAGCCTATGTCC | vacA m1/m2-F | CAATCTGTCCAATCAAGCGAG |
| 16S rRNA-R | TGGCAATCAGCGTCAGGTAATG | vacA m1/m2-R | GCGTCAAAATAATTCCAAGG |
| CagA-F | GTTGATAACGCTGTCGCTTC | UreB-F | AGTAGCCCGGTGAACACAACATCCT |
| CagA-R | GGGTTGTATGATATTTTCCATAA | UreB-R | ATGCCTTTGTCATAAGCCGCTTGG |
| vacA s1/s2-F | ATGGAAATACAACAAACACAC | UreA-F | TGATGGGACCAACTCGTAACCGT |
| vacA s1/s2-R | CTGCTTGAATGCGCCAAAC | UreA-R | CGCAATGTCTAAGCGTTTGCCGAA |
Table 6 Typing of Helicobacter pylori strains
| No. | CagA | VacA | UreA | UreB | Helicobacter pylori strain type |
| 1 | + | + | + | - | I |
| 2 | + | + | + | + | I |
| 3 | + | + | + | + | I |
| 4 | + | + | + | + | I |
| 5 | + | + | + | - | I |
| 6 | - | + | + | + | I |
| 7 | + | + | + | + | I |
| 8 | - | + | + | + | I |
| 9 | + | + | + | + | I |
| 10 | + | + | + | + | I |
| 11 | + | + | + | + | I |
| 12 | - | + | + | + | I |
Table 7 Minimum inhibitory concentration of antibiotics against 12 clinical strains of Helicobacter pylori
| Helicobacter pylori strain | AML (μg/mL) | CLR (μg/mL) | LEV (μg/mL) | MTZ (μg/mL) |
| 1 | 0.016 | 16.0001 | 32.0001 | 64.001 |
| 2 | 0.064 | 24.0001 | 32.0001 | 256.001 |
| 3 | 0.016 | 8.0001 | 32.0001 | 256.001 |
| 4 | 0.064 | 16.0001 | 32.0001 | 256.001 |
| 5 | 0.064 | 32.0001 | 0.125 | 256.001 |
| 6 | 0.016 | 8.0001 | 3.0001 | 1.00 |
| 7 | 0.064 | 16.0001 | 32.0001 | 0.38 |
| 8 | 0.016 | 0.016 | 0.250 | 32.001 |
| 9 | 0.016 | 0.064 | 0.094 | 256.001 |
| 10 | 0.016 | 0.016 | 1.500 | 0.50 |
| 11 | 0.016 | 0.016 | 0.032 | 1.00 |
| 12 | 0.016 | 0.016 | 0.032 | 1.50 |
Table 8 Minimum inhibitory concentration of Qingre Huashi decoction against Helicobacter pylori
| Helicobacter pylori strain | Concentration of QHD (mg/mL) | |||||
| NC (0) | 16 | 32 | 64 | 128 | 256 | |
| 1 | + | + | + | - | - | - |
| 2 | + | + | + | - | - | - |
| 3 | + | + | + | - | - | - |
| 4 | + | + | + | - | - | - |
| 5 | + | + | + | - | - | - |
| 6 | + | + | + | - | - | - |
| 7 | + | + | + | - | - | - |
| 8 | + | + | - | - | - | - |
| 9 | + | + | + | - | - | - |
| 10 | + | + | + | - | - | - |
| 11 | + | + | + | - | - | - |
| 12 | + | + | + | - | - | - |
- Citation: Lin MM, Yang SS, Huang QY, Cui GH, Jia XF, Yang Y, Shi ZM, Ye H, Zhang XZ. Effect and mechanism of Qingre Huashi decoction on drug-resistant Helicobacter pylori. World J Gastroenterol 2024; 30(24): 3086-3105
- URL: https://www.wjgnet.com/1007-9327/full/v30/i24/3086.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i24.3086
